News
A UArizona Health Sciences-led study identified poor childhood nutrition and growth as risk factors for lung disease and weaker health as an adult.
Bacterial lysate OM-85 blocked SARS-CoV-2 infection by decreasing the coronavirus's ability to bind to the lung cell surface receptor ACE2, research found.
19, Study Finds Bacterial lysate OM-85 blocked SARS-CoV-2 infection by decreasing the coronavirus's ability to bind to the lung cell surface receptor ACE2, research found.
TUCSON, Ariz. — A University of Arizona College of Medicine-Tucson researcher and her team think they may have found something that could prevent or treat COVID-19.
A research team will study how to better control severe asthma and determine why sufferers are less likely to contract COVID-19, influenza and rhinovirus.
A research team will study how to better control severe asthma and determine why sufferers are less likely to contract COVID-19, influenza and rhinovirus.
The Asthma & Airway Disease Research Center has revolutionized our scientific understanding of asthma and other respiratory diseases. Nearly 340 million people globally and 25 million Americans – 7.7% of adults and 8.4% of children – suffer from asthma. And while there’s no cure, five decades of leading-edge research at the University of Arizona Health Sciences has helped advance scientific understanding of this respiratory illness and the therapies developed to address it.
Researchers are taking a three-pronged approach to analyze asthma in children in Nogales, Sonora, Mexico, and Tucson, Arizona – even before they’re born. A cross-border investigation of children’s susceptibility to asthma and other childhood illnesses in the United States and Mexico is the focus of a new study led by researchers in the Asthma and Airway Disease Research Center at the University of Arizona Health Sciences.
A $2.2 million federal grant will allow Dr. Eugene Chang, a sinus surgeon at the UArizona College of Medicine - Tucson, to investigate human genetic viral interactions in the development of sinus disease.
The study objective was to examine the effect of COVID-19 on treatment adherence and self-reported sleep duration among patients with Obstructive Sleep Apnea (OSA) treated with positive airway pressure (PAP) therapy.